ISG15 and leukemia: To verify these effects, the lymphoma cell line Jurkat, leukemia cell line K562 and myeloma cell line RPMI-8226 were treated for 24 hrs by CLQ at increasing concentrations, both RT-PCR and immunoblotting analyses demonstrated that ISG15 was induced in a concentration-dependent manner (Figure 1A and 1B).